Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting | Journal of Clinical
Human Kappa Free Light Chain Assay | Diazyme Laboratories, Inc.
Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates - Hristov - 2020 - Journal of Cutaneous Pathology - Wiley Online Library
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study - CE Leurs, HAM Twaalfhoven, BI Lissenberg-Witte, V van Pesch, I Dujmovic, J Drulovic, M
Paraproteinaemia and Laboratory Investigation of Suspected Multiple Myeloma
Instruction for Use (eIFU) , N Latex FLC kappaN FLCKAPPA N Latex FLC lambdaN FLCLAMBDA
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Serum levels of (A) free kappa, (B) free lambda light chains and (C)... | Download Scientific Diagram
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
What are Free Kappa Light Chains, Serum? – HealthMatters.io – Lab results explained
PDF] Polyclonal free light chains: a biomarker of inflammatory disease or treatment target? | Semantic Scholar
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse - ScienceDirect
Serum free light chain is associated with histological activity and cirrhosis in patients with chronic hepatitis B - ScienceDirect
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study